Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EdeDay is a Japanese digital health company dedicated to improving the quality of life and care for patients living with Amyotrophic Lateral Sclerosis (ALS). The company provides a specialized digital platform and mobile application designed to facilitate communication between patients, caregivers, and healthcare providers, while also offering tools for symptom tracking and disease management. By leveraging data and technology, EdeDay aims to streamline the complex care requirements of ALS patients and support the administration of therapies such as edaravone. The company's services are primarily focused on the Japanese market, where it collaborates with medical institutions to enhance patient support systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ededay.